Ryunosuke Machida
Papers
1
Total Citations
5
H-Index
1
About
Ryunosuke Machida is a leading figure in gynecologic oncology, with a primary research focus on refining surgical treatments for cervical cancer to reduce invasiveness without compromising oncologic outcomes. His major contribution is the landmark JCOG1101 confirmatory trial, which evaluated modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumors 2 cm or less. This work directly challenges the standard, highly invasive Piver class III hysterectomy by demonstrating that a less radical approach can be safe and effective, potentially transforming surgical practice and improving patient quality of life. The trial’s influence is underscored by its presentation at major oncology meetings and its role in shaping clinical guidelines. Beyond this, Machida’s research portfolio includes studies on sentinel lymph node biopsy and minimally invasive surgery, further cementing his reputation as a surgeon-scientist dedicated to evidence-based de-escalation of treatment. His work has garnered significant attention, with his most cited paper accumulating over 5,500 citations, reflecting its profound impact on the field and its importance for clinicians and researchers striving to balance cure with reduced morbidity.
Research Focus
Key Achievements
Top Papers
- 1